Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson's disease

Lancet. 1997 Dec 6;350(9092):1676. doi: 10.1016/s0140-6736(05)64273-0.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Antiparkinson Agents / adverse effects*
  • Electric Stimulation Therapy*
  • Humans
  • Levodopa / adverse effects*
  • Middle Aged
  • Movement Disorders / etiology*
  • Movement Disorders / therapy
  • Parkinson Disease / therapy*
  • Thalamic Nuclei*
  • Thalamus / surgery
  • Treatment Outcome

Substances

  • Antiparkinson Agents
  • Levodopa